Flavoxate
Also sold as: FLAVOXATE HYDROCHLORIDE
Related Medications
These drugs share a pharmacologic classification but are NOT interchangeable. Listing here does not imply clinical equivalence. A physician must evaluate each drug individually for the patient's specific condition.
Classification: Cholinergic Muscarinic Antagonists (source: RxClass/NLM)
- tolterodineCholinergic Muscarinic AntagonistSame Class
- atropineCholinergic Muscarinic AntagonistSame Class
- darifenacinCholinergic Muscarinic AntagonistSame Class
- glycopyrroniumCholinergic Muscarinic AntagonistSame Class
- trospiumCholinergic Muscarinic AntagonistSame Class
- homatropineCholinergic Muscarinic AntagonistSame Class
- solifenacinCholinergic Muscarinic AntagonistSame Class
- oxybutyninCholinergic Muscarinic AntagonistSame Class
Insurance Coverage User-Reported
No community coverage data yet for flavoxate.
Coverage data submission coming soon.
Drug Information
Indications & Uses
INDICATIONS AND USAGE Flavoxate HCl tablets are indicated for symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis. Flavoxate HCl tablets are not indicated for definitive treatment, but are compatible with drugs used for the treatment of urinary tract infections.
Dosage & Administration
DOSAGE AND ADMINISTRATION Adults and children over 12 years of age: One or two 100 mg tablets 3 or 4 times a day. With improvement of symptoms, the dose may be reduced. This drug cannot be recommended for infants and children under 12 years of age because safety and efficacy have not been demonstrated in this age group.
Warnings & Precautions
WARNINGS Flavoxate HCl should be given cautiously in patients with suspected glaucoma.
Side Effects (Adverse Reactions)
ADVERSE REACTIONS The following adverse reactions have been observed, but there are not enough data to support an estimate of their frequency. Gastrointestinal: Nausea, vomiting, dry mouth. CNS: Vertigo, headache, mental confusion, especially in the elderly, drowsiness, nervousness. Hematologic: Leukopenia (one case which was reversible upon discontinuation of the drug). Cardiovascular: Tachycardia and palpitation. Allergic: Urticaria and other dermatoses, eosinophilia and hyperpyrexia. Ophthalmic: Increased ocular tension, blurred vision, disturbance in eye accommodation. Renal: Dysuria.
Contraindications
CONTRAINDICATIONS Flavoxate HCl tablets are contraindicated in patients who have any of the following obstructive conditions: pyloric or duodenal obstruction, obstructive intestinal lesions or ileus, achalasia, gastrointestinal hemorrhage and obstructive uropathies of the lower urinary tract.
Verify with Primary Sources
Always verify clinical information with authoritative sources.
Medical Disclaimer: Information on this page is sourced from FDA-approved labeling data and is for educational reference only. It does not constitute medical advice. This information does not establish a provider-patient relationship. Always verify with current prescribing information and consult a licensed healthcare professional before any clinical decision. Read full disclaimer.
Data sourced from RxNorm (NLM/NIH), FDA Orange Book, OpenFDA, DailyMed. Last updated: 2026-03-02.